Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Non-Current Assets (2016 - 2025)

AC Immune has reported Other Non-Current Assets over the past 11 years, most recently at $730683.2 for Q4 2025.

  • Quarterly Other Non-Current Assets rose 54.24% to $730683.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $730683.2 through Dec 2025, up 54.24% year-over-year, with the annual reading at $730683.2 for FY2025, 54.24% up from the prior year.
  • Other Non-Current Assets was $730683.2 for Q4 2025 at AC Immune, roughly flat from $730064.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $407.0 million in Q4 2023 and troughed at $373799.8 in Q3 2022.
  • The 5-year median for Other Non-Current Assets is $477227.1 (2024), against an average of $98.5 million.
  • Year-over-year, Other Non-Current Assets skyrocketed 126077.32% in 2021 and then crashed 99.91% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $393.7 million in 2021, then plummeted by 99.9% to $374725.9 in 2022, then skyrocketed by 108506.04% to $407.0 million in 2023, then plummeted by 99.88% to $473731.6 in 2024, then surged by 54.24% to $730683.2 in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Other Non-Current Assets are $730683.2 (Q4 2025), $730064.0 (Q3 2025), and $705407.9 (Q2 2025).